Literature DB >> 17412889

PECAM-1: a multifaceted regulator of megakaryocytopoiesis.

Yue Wu1, Thomas Welte, Michael Michaud, Joseph A Madri.   

Abstract

PECAM-1 (CD31) knockout (KO) mice exhibit excessive megakaryocytopoiesis accompanied by increased numbers of megakaryocytes associated with the stromal niche rather than the vascular niche. During earlier stages of megakaryocytopoiesis in KO marrow, an expanded Lin(-)Sca-1(+) c-kit(+) hematopoietic stem cell (HSC) population and increased quiescent Lin(-) progenitor pool were identified. During the later stages of megakaryocytopoiesis, CD31KO megakaryocytes exhibited abnormal adhesion/transmigration behaviors. Lastly, KO animals exhibited excessive splenic extramedullary megakaryocytopoiesis, which likely compensates for the impaired marrow megakaryocytopoiesis, resulting in normal peripheral platelet number. Thus, PECAM-1 modulates megakaryocytopoiesis in a hierarchic manner, functioning as a thermostat to "fine-tune" megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412889      PMCID: PMC1924763          DOI: 10.1182/blood-2006-05-022087

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation.

Authors:  N Ilan; L Cheung; E Pinter; J A Madri
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations.

Authors:  Purba Biswas; Jin Zhang; Jonathan D Schoenfeld; David Schoenfeld; Dita Gratzinger; Sandra Canosa; Joseph A Madri
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

3.  Pecam-1 is a modulator of stat family member phosphorylation and localization: lessons from a transgenic mouse.

Authors:  N Ilan; L Cheung; S Miller; A Mohsenin; A Tucker; J A Madri
Journal:  Dev Biol       Date:  2001-04-01       Impact factor: 3.582

4.  PECAM-1 (CD31) expression modulates bleeding time in vivo.

Authors:  S Mahooti; D Graesser; S Patil; P Newman; G Duncan; T Mak; J A Madri
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Functional heterogeneity within rhodamine123(lo) Hoechst33342(lo/sp) primitive hemopoietic stem cells revealed by pyronin Y.

Authors:  A Hüttmann; S L Liu; A W Boyd; C L Li
Journal:  Exp Hematol       Date:  2001-09       Impact factor: 3.084

6.  Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis.

Authors:  Anna Solowiej; Purba Biswas; Donnasue Graesser; Joseph A Madri
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 7.  PECAM-1: old friend, new partners.

Authors:  Neta Ilan; Joseph A Madri
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

8.  Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.

Authors:  Dita Gratzinger; Sandra Canosa; Britta Engelhardt; Joseph A Madri
Journal:  FASEB J       Date:  2003-08       Impact factor: 5.191

Review 9.  Regulation of B cell activation by PECAM-1: implications for the development of autoimmune disorders.

Authors:  Mae-Xhum Wong; Denise E Jackson
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.

Authors:  Scott T Avecilla; Koichi Hattori; Beate Heissig; Rafael Tejada; Fang Liao; Koji Shido; David K Jin; Sergio Dias; Fan Zhang; Travis E Hartman; Neil R Hackett; Ronald G Crystal; Larry Witte; Daniel J Hicklin; Peter Bohlen; Dan Eaton; David Lyden; Fredric de Sauvage; Shahin Rafii
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

View more
  13 in total

1.  An alternatively spliced isoform of PECAM-1 is expressed at high levels in human and murine tissues, and suggests a novel role for the C-terminus of PECAM-1 in cytoprotective signaling.

Authors:  Carmen Bergom; Cathy Paddock; Cunji Gao; Trudy Holyst; Debra K Newman; Peter J Newman
Journal:  J Cell Sci       Date:  2008-04-15       Impact factor: 5.285

2.  Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Ajoy Bhupatiraju; Kelley A Burridge; Hillary A Johnston-Cox; Anna Rita Migliaccio; John D Crispino; Hector A Lucero; Philip C Trackman; Katya Ravid
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

3.  Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.

Authors:  Stephanie N Zimmer; Qing Zhou; Ting Zhou; Ziming Cheng; Sherry L Abboud-Werner; Diane Horn; Mike Lecocke; Ruth White; Andrei V Krivtsov; Scott A Armstrong; Andrew L Kung; David M Livingston; Vivienne I Rebel
Journal:  Blood       Date:  2011-05-09       Impact factor: 22.113

4.  Integrin-αvβ3 regulates thrombopoietin-mediated maintenance of hematopoietic stem cells.

Authors:  Terumasa Umemoto; Masayuki Yamato; Jun Ishihara; Yoshiko Shiratsuchi; Mika Utsumi; Yohei Morita; Hiroko Tsukui; Masao Terasawa; Takehiko Shibata; Kohji Nishida; Yoshiro Kobayashi; Brian G Petrich; Hiromitsu Nakauchi; Koji Eto; Teruo Okano
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

5.  Whole genome sequence analysis of platelet traits in the NHLBI Trans-Omics for Precision Medicine (TOPMed) initiative.

Authors:  Amarise Little; Yao Hu; Quan Sun; Deepti Jain; Jai Broome; Ming-Huei Chen; Florian Thibord; Caitlin McHugh; Praveen Surendran; Thomas W Blackwell; Jennifer A Brody; Arunoday Bhan; Nathalie Chami; Paul S de Vries; Lynette Ekunwe; Nancy Heard-Costa; Brian D Hobbs; Ani Manichaikul; Jee-Young Moon; Michael H Preuss; Kathleen Ryan; Zhe Wang; Marsha Wheeler; Lisa R Yanek; Goncalo R Abecasis; Laura Almasy; Terri H Beaty; Lewis C Becker; John Blangero; Eric Boerwinkle; Adam S Butterworth; Hélène Choquet; Adolfo Correa; Joanne E Curran; Nauder Faraday; Myriam Fornage; David C Glahn; Lifang Hou; Eric Jorgenson; Charles Kooperberg; Joshua P Lewis; Donald M Lloyd-Jones; Ruth J F Loos; Yuan-I Min; Braxton D Mitchell; Alanna C Morrison; Deborah A Nickerson; Kari E North; Jeffrey R O'Connell; Nathan Pankratz; Bruce M Psaty; Ramachandran S Vasan; Stephen S Rich; Jerome I Rotter; Albert V Smith; Nicholas L Smith; Hua Tang; Russell P Tracy; Matthew P Conomos; Cecelia A Laurie; Rasika A Mathias; Yun Li; Paul L Auer; Timothy Thornton; Alexander P Reiner; Andrew D Johnson; Laura M Raffield
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

Review 6.  Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche.

Authors:  Huichun Zhan; Kenneth Kaushansky
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 7.  ITIM receptors: more than just inhibitors of platelet activation.

Authors:  Carmen H Coxon; Mitchell J Geer; Yotis A Senis
Journal:  Blood       Date:  2017-05-02       Impact factor: 22.113

8.  JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia.

Authors:  Catherine M Hobbs; Harriet Manning; Cavan Bennett; Louella Vasquez; Sonia Severin; Lauren Brain; Alexandra Mazharian; Jose A Guerrero; Juan Li; Nicole Soranzo; Anthony R Green; Steve P Watson; Cedric Ghevaert
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113

9.  Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.

Authors:  Leonor Remédio; Tânia Carvalho; Francisco Caiado; Ana Bastos-Carvalho; Diana Martins; António Duarte; Hideo Yagita; Sergio Dias
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Innate immunity and resistance to tolerogenesis in allotransplantation.

Authors:  Gilles Benichou; Makoto Tonsho; Georges Tocco; Ognjenka Nadazdin; Joren C Madsen
Journal:  Front Immunol       Date:  2012-04-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.